Roche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up to Novo Nordisk and Eli Lilly in a class of medicines that has shaken up everything from pharma to snack companies.
Trending
- AI language models duped by poems – DW – 12/16/2025
- Series show: Emily trades Paris for La Dolce Vita in Rome
- Trump sues BBC for $10bn in lawsuit | US News
- "Islamic State propaganda is maybe more audible" in Syria among those who resent new authorities
- Why Germany’s auto capitals face financial crisis – DW – 12/16/2025
- ‘Shambles’ as man dies from sepsis after 34-hour medication delay
- Unemployment rate jumps again, with young people worst affected | Money News
- Thousands of drivers wrongly fined for speeding since 2021
